1
/
of
0
FDA Drug Approval, N007513, LEVOPHED
FDA Drug Approval, N007513, LEVOPHED
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 007513
Company: HOSPIRA
Drug Name: LEVOPHED
Active Ingredients: NOREPINEPHRINE BITARTRATE
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AP
Submission Classification: PRIORITY
Company: HOSPIRA
Drug Name: LEVOPHED
Active Ingredients: NOREPINEPHRINE BITARTRATE
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AP
Submission Classification: PRIORITY
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details